Cardiovascular disease (CVD) remains the most common cause of death across Europe but while CVD mortality rates are generally decreasing, the decline is much less in middle-income than in high-income countries, according to new data from the European Society of Cardiology (ESC) Atlas of Cardiology, published in the European Heart Journal.
Sanofi and AstraZeneca to make 230,000 additional RSV immunizations available, White House says
RSV vaccine manufacturers Sanofi and AstraZeneca will make 230,000 more doses of their immunizations for infants available beginning in January to address high demand, the